| Literature DB >> 32488388 |
Susanne Minkus1,2, Sylvia Grosse1,3, Stefan Bieber2, Sofia Veloutsou1,4, Thomas Letzel5,6.
Abstract
Highly polar trace organic compounds, which are persistent, mobile, and toxic (PMT) or are very persistent and very mobile (vPvM) in the aquatic environment, may pose a risk to surface water, ground water, and drinking water supplies. Despite the advances in liquid chromatography-mass spectrometry, there often exists an analytical blind spot when it comes to very polar chemicals. This study seeks to make a broad polarity range analytically accessible by means of serially coupling reversed-phase liquid chromatography (RPLC) and hydrophilic interaction liquid chromatography (HILIC) to high-resolution mass spectrometry (HRMS). Moreover, a workflow is presented using optimized data processing of nontarget screening (NTS) data and subsequently generating candidate lists for the identification of very polar molecules via an open-access NTS platform and implemented compound database. First, key input parameters and filters of the so-called feature extraction algorithms were identified, and numerical performance indicators were defined to systematically optimize the data processing method. Second, all features from the very polar HILIC elution window were uploaded to the STOFF-IDENT database as part of the FOR-IDENT open-access NTS platform, which contains additional physicochemical information, and the features matched with potential compounds by their accurate mass. The hit list was filtered for compounds with a negative log D value, indicating that they were (very) polar. For instance, 46 features were assigned to 64 candidate compounds originating from a set of 33 samples from the Isar river in Germany. Three PMT candidates (e.g., guanylurea, melamine, and 1,3-dimethylimidazolidin-2-one) were illustratively validated using the respective reference standards. In conclusion, these findings demonstrate that polarity-extended chromatography reproducibly retards and separates (very) polar compounds from surface waters. These findings further indicate that a transparent and robust data processing workflow for nontarget screening data is available for addressing new (very) polar substances in the aqueous environment.Entities:
Keywords: DoE; High-resolution mass spectrometry; Hydrophilic interaction liquid chromatography; Optimization; PMTs; vPvMs
Year: 2020 PMID: 32488388 PMCID: PMC8206052 DOI: 10.1007/s00216-020-02743-0
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
The robust setpoint is presented as a result of optimizing the critical FE parameters. For each quantitative factor, the respective value and the factor contribution were calculated
| Quantitative factor | Value | Contribution (%) |
|---|---|---|
| F1 | 0 counts | 9.0 |
| F2 | 1 | 5.4 |
| F3 | 0.87 min | 46.1 |
| F4 | 50 ppm | 0.0 |
| F5 | 0 counts | 0.0 |
| F6 | 5000 counts | 2.0 |
| F7 | 5000 counts | 26.6 |
| F8 | 10 ppm | 10.9 |
Fig. 1Workflow to evaluate nontarget screening data including a compound database search. Input parameters and filtering steps which significantly influence the output after each step are depicted in orange and blue boxes, respectively. The bolt numbers in brackets mark the critical parameters that were optimized
Fig. 2Mass-RT plot of features obtained from measuring 33 environmental samples with a RPLC-HILIC-TOF-MS coupling. All blank masses were excluded in the extraction method. The features can be separated into two distinct groups, the first of which represents those that eluted from the HILIC column
Features described by their detected accurate masses and mean RTs with RSDs. They are presented along with the respective database hit(s). The features eluted from the HILIC column of the RPLC-HILIC-TOF-MS coupling and therefor only compounds with a negative log D value were considered
| ID | Detected median mass | Detected mean RT (min) | Number of samples | RSD RT (%) | Compound name (STOFF-IDENT) | InChi key | Relative mass difference (ppm) | Log |
|---|---|---|---|---|---|---|---|---|
| 1 | 75.0688 | 13.8 | 10 | 0.3 | 3-Aminopropan-1-ol | WUGQZFFCHPXWKQ-UHFFFAOYSA-N | 5.3 | − 3.9 |
| 1-Aminopropan-2-ol | HXKKHQJGJAFBHI-UHFFFAOYSA-N | 5.3 | − 3.4 | |||||
| 2-Methylaminoethanol | OPKOKAMJFNKNAS-UHFFFAOYSA-N | 5.3 | − 3.6 | |||||
| 2-Amino-1-propanol | BKMMTJMQCTUHRP-UHFFFAOYSA-N | 5.3 | − 3.5 | |||||
| 2 | 102.0547 | 14.6 | 13 | 1.6 | Guanylurea | SQSPRWMERUQXNE-UHFFFAOYSA-N | 4.9 | − 2.1 |
| 3 | 103.1001 | 12.4 | 3 | 0.6 | 3-Ethoxypropylamine | SOYBEXQHNURCGE-UHFFFAOYSA-N | 3.9 | − 3.0 |
| 1-Dimethylaminopropan-2-ol | NCXUNZWLEYGQAH-UHFFFAOYSA-N | 3.9 | − 2.3 | |||||
| 3-Dimethylaminopropan-1-ol | PYSGFFTXMUWEOT-UHFFFAOYSA-N | 3.9 | − 2.6 | |||||
| 4 | 109.0532 | 7.4 | 9 | 0.2 | (1R,4S)-2-Azabicyclo[2.2.1]hept-5-en-3-one | DDUFYKNOXPZZIW-UHFFFAOYSA-N | 3.7 | − 0.2 |
| Nicotinylalcohol | MVQVNTPHUGQQHK-UHFFFAOYSA-N | 3.7 | 0.0 | |||||
| 5 | 113.1205 | 11.0 | 3 | 2.8 | 1-Ethylpiperidine | HTLZVHNRZJPSMI-UHFFFAOYSA-N | 0.9 | − 1.5 |
| 6 | 114.0795 | 5.6 | 11 | 0.5 | 1,3-Dimethylimidazolidin-2-one | CYSGHNMQYZDMIA-UHFFFAOYSA-N | 1.8 | − 0.6 |
| 7 | 115.0627 | 12.1 | 11 | 0.8 | N-(Hydroxymethyl)methacrylamide | DNTMQTKDNSEIFO-UHFFFAOYSA-N | − 5.2 | − 0.2 |
| 4-Morpholinecarbaldehyde | LCEDQNDDFOCWGG-UHFFFAOYSA-N | − 5.2 | − 0.9 | |||||
| N-(2-Hydroxyethyl)prop-2-enamide | UUORTJUPDJJXST-UHFFFAOYSA-N | − 5.2 | − 0.7 | |||||
| Methyl-3-aminocrotonate | XKORCTIIRYKLLG-ONEGZZNKSA-N | − 5.2 | − 0.24 | |||||
| 8 | 115.0995 | 7.9 | 15 | 1.7 | 2,6-Dimethylmorpholine | HNVIQLPOGUDBSU-UHFFFAOYSA-N | − 1.7 | − 1.3 |
| Trans-4-Aminocyclohexan-1-ol | IMLXLGZJLAOKJN-UHFFFAOYSA-N | − 1.7 | − 3.0 | |||||
| 2-Pyrrolidin-1-ylethanol | XBRDBODLCHKXHI-UHFFFAOYSA-N | − 1.7 | − 2.7 | |||||
| 9 | 117.0798 | 11.7 | 30 | 0.8 | KZSNJWFQEVHDMF-BYPYZUCNSA-N | 6.8 | − 2.0 | |
| SNDPXSYFESPGGJ-BYPYZUCNSA-N | 6.8 | − 1.9 | ||||||
| 2-Hydroxy-N,N-dimethyl-propanamide | YEBLAXBYYVCOLT-UHFFFAOYSA-N | 6.8 | − 0.8 | |||||
| 10 | 121.0883 | 5.2 | 8 | 0.1 | RQEUFEKYXDPUSK-SSDOTTSWSA-N | − 6.6 | − 1.0 | |
| Benzyl(methyl)amine | RIWRFSMVIUAEBX-UHFFFAOYSA-N | − 6.6 | − 1.1 | |||||
| RQEUFEKYXDPUSK-ZETCQYMHSA-N | − 6.6 | − 1.0 | ||||||
| Phenethylamine (PEA) | BHHGXPLMPWCGHP-UHFFFAOYSA-N | − 6.6 | − 1.2 | |||||
| 11 | 126.0651 | 7.2 | 5 | 1.6 | Melamine | JDSHMPZPIAZGSV-UHFFFAOYSA-N | − 2.4 | − 2.0 |
| 126.0655 | 6.9 | 4 | 0.5 | 0.8 | ||||
| 126.0665 | 8.4 | 9 | 0.2 | 8.7 | ||||
| 12 | 129.0182 | 6.3 | 8 | 2.9 | 1,3,5-Triazinane-2,4,6-trione | ZFSLODLOARCGLH-UHFFFAOYSA-N | 6.2 | − 1.1 |
| 13 | 135.0554 | 7.7 | 4 | 0.3 | Adenine | GFFGJBXGBJISGV-UHFFFAOYSA-N | 6.7 | − 0.6 |
| 14 | 144.0904 | 6.3 | 17 | 2.1 | N,N′-Ethylenedi(diacetamide) | WNYIBZHOMJZDKN-UHFFFAOYSA-N | 3.5 | − 1.8 |
| 15 | 149.0709 | 7.6 | 4 | 0.6 | 3-Methyladenine | ZPBYVFQJHWLTFB-UHFFFAOYSA-N | 5.4 | − 0.3 |
| 1-Methyladenine | SATCOUWSAZBIJO-UHFFFAOYSA-N | 5.4 | − 0.5 | |||||
| 9-Methyladenine | WRXCXOUDSPTXNX-UHFFFAOYSA-N | 5.4 | − 0.3 | |||||
| 7-Methyladenine | HCGHYQLFMPXSDU-UHFFFAOYSA-N | 5.4 | − 0.4 | |||||
| 16 | 149.1046 | 12.2 | 10 | 1.0 | 2,2′,2″-Nitrilotriethanol | GSEJCLTVZPLZKY-UHFFFAOYSA-N | − 4.0 | − 3.3 |
| 2-(Dimethylamino)-2-(hydroxymethyl)propane-1,3-diol | FGLZHYIVVZTBQJ-UHFFFAOYSA-N | − 4.0 | − 3.4 | |||||
| 17 | 149.1052 | 11.2 | 17 | 1.0 | 2,2′,2″-Nitrilotriethanol | GSEJCLTVZPLZKY-UHFFFAOYSA-N | 0.0 | − 3.3 |
| 2-(Dimethylamino)-2-(hydroxymethyl)propane-1,3-diol | FGLZHYIVVZTBQJ-UHFFFAOYSA-N | 0.0 | − 3.4 | |||||
| 18 | 155.1311 | 8.6 | 19 | 3.0 | 2,2,6,6-Tetramethyl-4-piperidone | JWUXJYZVKZKLTJ-UHFFFAOYSA-N | 0.6 | − 0.3 |
| 2-[(Dimethylamino)methyl]cyclohexanone | QDHLEFBSGUGHCL-UHFFFAOYSA-N | 0.6 | − 0.3 | |||||
| 19 | 155.1316 | 6.2 | 17 | 1.7 | 2,2,6,6-Tetramethyl-4-piperidone | JWUXJYZVKZKLTJ-UHFFFAOYSA-N | 3.9 | − 0.3 |
| 2-[(Dimethylamino)methyl]cyclohexanone | QDHLEFBSGUGHCL-UHFFFAOYSA-N | 3.9 | − 0.3 | |||||
| 20 | 161.1413 | 15.1 | 3 | 0.9 | 2-[2-(Diethylamino)ethoxy]ethanol | VKBVRNHODPFVHK-UHFFFAOYSA-N | − 1.9 | − 2.2 |
| (2,2-Diethoxyethyl)dimethylamine | SSFAUOAQOOISRQ-UHFFFAOYSA-N | − 1.9 | − 0.1 | |||||
| 7,7-Dimethyl-3-oxa-6-azaoctan-1-ol | YDEDDFNFQOPRQJ-UHFFFAOYSA-N | − 1.9 | − 2.6 | |||||
| 21 | 163.0859 | 15.0 | 6 | 0.5 | Bicine | FSVCELGFZIQNCK-UHFFFAOYSA-N | 8.6 | − 4.4 |
| 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4R,5S)- | LXBIFEVIBLOUGU-JGWLITMVSA-N | 8.6 | − 4.0 | |||||
| 22 | 170.0932 | 7.3 | 3 | 0.4 | (1R,3S)-2,2-Dimethyl-3-(2-oxopropyl)cyclopropanecarboxylic acid | BKUHNVYPRVILOX-BQBZGAKWSA-N | − 6.5 | − 1.6 |
| 23 | 171.0907 | 7.9 | 8 | 0.3 | Ethyl 2-oxopyrrolidine-1-acetate | AQZWKPDVWWJWRY-UHFFFAOYSA-N | 7.0 | − 0.4 |
| 24 | 187.1211 | 8.1 | 10 | 0.2 | (3R)-3-(2-Amino-2-oxoethyl)-5-methylhexanoic acid | NPDKTSLVWGFPQG-UHFFFAOYSA-N | 1.6 | − 1.5 |
| 25 | 191.1518 | 6.6 | 11 | 1.8 | 1,1′,1″-Nitrilotripropan-2-ol | SLINHMUFWFWBMU-UHFFFAOYSA-N | − 1.6 | − 2.9 |
| 191.1523 | 8.3 | 3 | 1.3 | 1.1 | ||||
| 26 | 201.1733 | 9.5 | 33 | 2.1 | 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-ethanol | STEYNUVPFMIUOY-UHFFFAOYSA-N | 2.0 | − 2.6 |
| 201.1734 | 10.9 | 11 | 0.3 | 2.5 | ||||
| 201.1737 | 8.4 | 3 | 2.1 | 4.0 | ||||
| 201.1740 | 9.8 | 5 | 0.7 | 5.5 | ||||
| 201.1742 | 10.9 | 11 | 0.3 | 6.5 | ||||
| 27 | 205.0599 | 11.8 | 6 | 0.9 | Methylglycinediacetic acid | CIEZZGWIJBXOTE-UHFFFAOYSA-N | 6.3 | − 9.9 |
| 28 | 205.1304 | 7.7 | 7 | 0.5 | Panthenol, | SNPLKNRPJHDVJA-UHFFFAOYSA-N | − 4.9 | − 1.7 |
| Dexpanthenol | SNPLKNRPJHDVJA-ZETCQYMHSA-N | − 4.9 | − 1.7 | |||||
| 29 | 205.1327 | 5.7 | 11 | 0.1 | Panthenol, | SNPLKNRPJHDVJA-UHFFFAOYSA-N | 6.3 | − 1.7 |
| Phenformin | ICFJFFQQTFMIBG-UHFFFAOYSA-N | 0.0 | − 3.8 | |||||
| Dexpanthenol | SNPLKNRPJHDVJA-ZETCQYMHSA-N | 6.3 | − 1.7 | |||||
| 30 | 221.1402 | 12.2 | 5 | 0.2 | 3,4-Methylenedioxypropylamphetamine | LBXMQBTXOLBCCA-UHFFFAOYSA-N | − 6.3 | − 0.3 |
| 31 | 222.1475 | 6.0 | 7 | 0.3 | Bis(2-(2-Methoxyethoxy)ethyl) ether | ZUHZGEOKBKGPSW-UHFFFAOYSA-N | 3.6 | − 0.1 |
| 2-Ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium | HNGQYAWKWBGGDR-UHFFFAOYSA-N | − 6.3 | − 2.4 | |||||
| 32 | 234.1106 | 6.6 | 8 | 3.9 | 2,2′-[Ethane-1,2-diylbis(oxy)]bisethyl diacetate | OVOUKWFJRHALDD-UHFFFAOYSA-N | 1.3 | − 0.4 |
| 33 | 257.1052 | 13.7 | 9 | 0.7 | Tolmetin | UPSPUYADGBWSHF-UHFFFAOYSA-N | 0.0 | − 0.2 |
| 34 | 267.1475 | 12.5 | 8 | 0.6 | Metoprolol acid | PUQIRTNPJRFRCZ-UHFFFAOYSA-N | 1.5 | − 1.2 |
| 35 | 283.1775 | 12.0 | 11 | 0.1 | Alpha-Hydroxymetoprolol | OFRYBPCSEMMZHR-UHFFFAOYSA-N | − 3.2 | − 1.7 |
| 36 | 360.2144 | 12.1 | 7 | 0.3 | Butylscopolamin | YBCNXCRZPWQOBR-FAQYLHNASA-N | − 7.0 | − 1.9 |
| Butylscopolammonium | YBCNXCRZPWQOBR-MWGADRMYSA-N | − 7.0 | − 1.9 | |||||
| 37 | 362.1668 | 9.9 | 16 | 0.5 | Protirelin | XNSAINXGIQZQOO-SRVKXCTJSA-N | − 9.7 | − 3.4 |
| 38 | 468.2676 | 11.6 | 4 | 0.2 | 6,6′,6″-(1,3,5-Triazine-2,4,6-triyltrimino)tris-hexanoic acid | BKKWPPMEXIXECW-UHFFFAOYSA-N | − 4.3 | − 5.3 |
| 39 | 475.2971 | 6.4 | 22 | 2.2 | Netilimicin | CIDUJQMULVCIBT-IULVMANBSA-N | − 7.4 | − 12.8 |
Fig. 3Spatial distribution along the Isar river of 46 features found in 33 environmental samples of 2015. They represent the portion of features that eluted from the HILIC column and have a database match with a log D < 0 at pH 7
Fig. 4The dot plot shows features that were detected in the March samples either upstream or downstream of Munich (circles, location IDs 8 and 9, Table S1) or just downstream of Munich (crosses). The features eluted from the HILIC column and were proposed by the STOFF-IDENT database. Only matches with a negative log D value were considered. The numbers indicate the ID of the database queries as are listed in Table 2
Three tentative compounds found by the nontarget screening approach that were confirmed via RT and accurate mass matching with a reference standard. For each compound, the monoisotopic mass of the underlying feature is shown as well as the mass difference. The reference RT is the mean value of the reference standard’s RT measured n times. ΔRT describes the RT deviation of the molecular feature from the reference standard
| Name | InChi key | Elemental formula | Log | Monoisotopic mass (Da) | Mass difference (ppm) | Reference RT (min) | Δ RT (%) |
|---|---|---|---|---|---|---|---|
| Guanylurea | BKMMTJMQCTUHRP-UHFFFAOYSA-N | C2H6N4O | − 2.1 | 102.0542 | 4.9 | 14.4 ( | 1.4 |
| Melamine | JDSHMPZPIAZGSV-UHFFFAOYSA-N | C3H6N6 | − 2.0 | 126.0654 | 0.8 | 7.0 ( | − 1.3 |
| 1,3-Dimethylimidazolidin-2-one | CYSGHNMQYZDMIA-UHFFFAOYSA-N | C5H10N2O | − 0.6 | 114.0793 | 1.8 | 5.9 ( | − 4.8 |